Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Koster

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|January 6, 1996
Hantavirus pulmonary syndrome-related virus from BoliviaB Hjelle, N Torrez-Martinez, F T Koster
Journal of Veterinary Pharmacology and Therapeutics|November 25, 2003
Emerging therapeutic agents for transmissible spongiform encephalopathies: a reviewT Koster, K Singh, M Zimmermann, et al.
The Netherlands Journal of Medicine|June 21, 2002
Selection for the internal medicine residency programme in the Leiden regionT Koster, R De Graaf, A E Meinders
British Journal of Haematology|October 1, 1989
Bleeding time, blood groups and von Willebrand factorK M Caekebeke-Peerlinck, T Koster, E Briët
Scandinavian Journal of Immunology|May 1, 1986
Well-defined cell-surface receptors may be entry points for infectious agentsR C Williams, G Husby, F T Koster
American Journal of Clinical Pathology|September 1, 1989
A randomized and blinded comparison of the sensitivity and the reproducibility of the Ivy and Simplate II bleeding time techniquesT Koster, K M Caekebeke-Peerlinck, E Briet
The American Journal of Medicine|November 1, 1983
Alterations in lymphocyte cell surface markers during various human infectionsR C Williams, F T Koster, K A Kilpatrick
Nature|November 28, 1970
The short lived small lymphocyte as a mediator of cellular immunityD D McGregor, F T Koster, G B Mackaness
The Journal of Experimental Medicine|August 1, 1989
Prostaglandins from human T suppressor/cytotoxic cells modulate natural killer antibacterial activityP Garcia-Peñarrubia, A D Bankhurst, F T Koster
European Journal of Internal Medicine|April 22, 2017
X-ChEXIT in screening for occult cancer in patients with a deep vein thrombosisW T Moest, C Kruydenberg, M Tan, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|January 6, 1996
Hantavirus pulmonary syndrome-related virus from BoliviaB Hjelle, N Torrez-Martinez, F T Koster
Journal of Veterinary Pharmacology and Therapeutics|November 25, 2003
Emerging therapeutic agents for transmissible spongiform encephalopathies: a reviewT Koster, K Singh, M Zimmermann, et al.
The Netherlands Journal of Medicine|June 21, 2002
Selection for the internal medicine residency programme in the Leiden regionT Koster, R De Graaf, A E Meinders
British Journal of Haematology|October 1, 1989
Bleeding time, blood groups and von Willebrand factorK M Caekebeke-Peerlinck, T Koster, E Briët
Scandinavian Journal of Immunology|May 1, 1986
Well-defined cell-surface receptors may be entry points for infectious agentsR C Williams, G Husby, F T Koster
American Journal of Clinical Pathology|September 1, 1989
A randomized and blinded comparison of the sensitivity and the reproducibility of the Ivy and Simplate II bleeding time techniquesT Koster, K M Caekebeke-Peerlinck, E Briet
The American Journal of Medicine|November 1, 1983
Alterations in lymphocyte cell surface markers during various human infectionsR C Williams, F T Koster, K A Kilpatrick
Nature|November 28, 1970
The short lived small lymphocyte as a mediator of cellular immunityD D McGregor, F T Koster, G B Mackaness
The Journal of Experimental Medicine|August 1, 1989
Prostaglandins from human T suppressor/cytotoxic cells modulate natural killer antibacterial activityP Garcia-Peñarrubia, A D Bankhurst, F T Koster
European Journal of Internal Medicine|April 22, 2017
X-ChEXIT in screening for occult cancer in patients with a deep vein thrombosisW T Moest, C Kruydenberg, M Tan, et al.
Pageof 10